Mifegymiso (mifepristone And Misoprostol Tablets) - Canadian Distribution And Administration Program

Recall Summary Mifegymiso, a medication containing mifepristone and misoprostol used for medical abortion, is being recalled in Canada due to manufacturing quality issues that could affect the drug's safety and effectiveness. The recall applies to all batches of this product distributed across Canada. Health Canada is overseeing the recall through the Canadian Distribution and Administration Program, which manages how this restricted medication is supplied to authorized providers.

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2017-05-18

Status

Closed

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/5b1de6fd-596d-449e-9521-1b80499c225c